Free Trial
OTCMKTS:TNGN

Tengion (TNGN) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
10,000 shs
Average Volume
6,051 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Tengion

Tengion, Inc. is a medicine company, focuses on discovering, developing, manufacturing and commercializing of neo-organs and products. The company was founded by Steven Nichtberger and David I. Scheer on July 10, 2003 and is headquartered in Winston-Salem, NC.

TNGN Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive TNGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tengion and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:TNGN
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • David I. Scheer (Age 63)
    Independent Chairman of the Board
  • Carl-Johan Dalsgaard M.D. (Age 56)
    Independent Director
  • Diane K. Jorkasky M.D. (Age 61)
    Independent Director
  • Richard E. Kuntz M.D. (Age 58)
    Independent Director
  • Lorin Jeffry Randall
    Independent Director

TNGN Stock Analysis - Frequently Asked Questions

How do I buy shares of Tengion?

Shares of TNGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:TNGN) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners